EXBLIFEP 2 g / 0.5 g powder for concentrate for solution for infusion

Licence status
Authorised: 21/03/2024
Active substances
Cefepime dihydrochloride monohydrate, Enmetazobactam
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/24/1794/001
Licence holder
Advanz Pharma Limited

Product documents

Licence information

ATC code
J01DE51 cefepime and beta-lactamase inhibitor
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
21/03/2024